Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
9054 | 1125 | 42.2 | 91% |
Classes in level above (level 2) |
ID, lev. above |
Publications | Label for level above |
---|---|---|
705 | 12205 | MATRIX METALLOPROTEINASES//CD147//MATRIX METALLOPROTEINASE |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | MORPHOL ESTOMATOL PHYSIOL | Address | 10 | 33% | 2% | 24 |
2 | 2K 1C HYPERTENSION | Author keyword | 5 | 63% | 0% | 5 |
3 | MED IPB HSL | Address | 4 | 75% | 0% | 3 |
4 | L99ES11 | Address | 3 | 100% | 0% | 3 |
5 | S PEDIAT ONCOHEMATOL IMMUNOL | Address | 3 | 100% | 0% | 3 |
6 | PHARM BIOCHEMINFIBIOC | Address | 2 | 67% | 0% | 2 |
7 | RECEPTOR CLEAVAGE | Author keyword | 2 | 43% | 0% | 3 |
8 | UCO CLIN MED GEN TER IA MED | Address | 2 | 43% | 0% | 3 |
9 | INT CARDIOVASC MED | Address | 1 | 100% | 0% | 2 |
10 | MATRIX METALLOPROTEINASE 9 2 | Author keyword | 1 | 50% | 0% | 2 |
Web of Science journal categories |
Author Key Words |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | 5A 6A POLYMORPHISM | 34 | 70% | 2% | 28 |
2 | GELATINASE B GENE | 20 | 54% | 2% | 26 |
3 | MMP 9 ACTIVITIES | 14 | 48% | 2% | 22 |
4 | PROMOTER 5A 6A POLYMORPHISM | 12 | 75% | 1% | 9 |
5 | 5A 6A PROMOTER POLYMORPHISM | 12 | 86% | 1% | 6 |
6 | MUSCLE CELL MIGRATION | 11 | 17% | 6% | 62 |
7 | PROMOTES VASOCONSTRICTION | 11 | 78% | 1% | 7 |
8 | STROMELYSIN 1 PROMOTER | 10 | 50% | 1% | 15 |
9 | AORTIC ANEURYSM WALL | 9 | 83% | 0% | 5 |
10 | CIRCULATING MATRIX METALLOPROTEINASES | 9 | 83% | 0% | 5 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references | % act. ref. to same field |
---|---|---|---|---|
Matrix metalloproteinases in vascular remodeling and atherogenesis - The good, the bad, and the ugly | 2002 | 1077 | 124 | 40% |
Metalloproteinase Expression in Monocytes and Macrophages and its Relationship to Atherosclerotic Plaque Instability | 2008 | 156 | 73 | 49% |
Metalloproteinases and vulnerable atherosclerotic plaques | 2007 | 92 | 48 | 67% |
Matrix metalloproteinases in metabolic syndrome | 2012 | 25 | 66 | 64% |
Matrix metalloproteinases in vascular physiology and disease | 2012 | 48 | 52 | 37% |
Dual role of matrix metalloproteinases (matrixins) in intimal thickening and atherosclerotic plaque rupture | 2005 | 433 | 299 | 31% |
Matrix Metalloproteinases in Atherothrombosis | 2010 | 69 | 228 | 48% |
Matrix metalloproteinase inhibition therapy for vascular diseases | 2012 | 53 | 202 | 27% |
Matrix metalloproteinases as biomarkers of disease: updates and new insights | 2015 | 1 | 33 | 42% |
Matrix Metalloproteinases: Inflammatory Regulators of Cell Behaviors in Vascular Formation and Remodeling | 2013 | 26 | 126 | 29% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | MORPHOL ESTOMATOL PHYSIOL | 10 | 33% | 2.1% | 24 |
2 | MED IPB HSL | 4 | 75% | 0.3% | 3 |
3 | L99ES11 | 3 | 100% | 0.3% | 3 |
4 | S PEDIAT ONCOHEMATOL IMMUNOL | 3 | 100% | 0.3% | 3 |
5 | PHARM BIOCHEMINFIBIOC | 2 | 67% | 0.2% | 2 |
6 | UCO CLIN MED GEN TER IA MED | 2 | 43% | 0.3% | 3 |
7 | INT CARDIOVASC MED | 1 | 100% | 0.2% | 2 |
8 | D CAMPANACCI CLIN MED PL BIOTECHNOL | 1 | 16% | 0.6% | 7 |
9 | PHYSIOPATHOL CLIN BIOCHEM | 1 | 25% | 0.4% | 4 |
10 | KYURIN OMTEST | 1 | 24% | 0.4% | 4 |
Related classes at same level (level 1) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000152583 | SAN ANTONIO CARDIOVASC PROTE//CARDIAC FIBROBLASTS//MISSISSIPPI HEART |
2 | 0.0000124520 | KANEMATSU//ISOLATED GLOMERULI//NEPHROL A |
3 | 0.0000122413 | MODIFIED TETRACYCLINE//IMPERIAL WELLCOME TRUST CLIN TROP MED//MAZANKOWSKI ALBERTA HEART PHARMACOL |
4 | 0.0000105134 | MT1 MMP//CANC CELL//MMP 2 |
5 | 0.0000096025 | SB 3CT//HEAD SHAKE RESPONSE//BBB BREAKDOWN |
6 | 0.0000072261 | TIMP 1//SORSBYS FUNDUS DYSTROPHY//SORSBY FUNDUS DYSTROPHY |
7 | 0.0000067899 | VEIN GRAFT//VEIN GRAFTS//INTIMAL HYPERPLASIA |
8 | 0.0000066210 | TUMOR TISSUE PROGRESSION//FIBROBLAST COLLAGENASE//CARRAGEENAN GRANULOMA |
9 | 0.0000060069 | ABDOMINAL AORTIC ANEURYSM//ABDOMINAL AORTIC ANEURYSMS//INTRALUMINAL THROMBUS |
10 | 0.0000059100 | GLC OXLDL//MOL VASC CELL BIOL//PATHOL AZ MIDDELHEIM |